Intimacy Plus 0.03 mg/0.15 mg Tablet
By Intimacy Plus
Rx
21 Tablet in a Strip

Composition
Ethinyl Estradiol(0.03mg) + Desogestrel(0.15mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd
Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after
August, 2026

liver
When using Intimacy Plus 0.03 mg/0.15 mg Tablet, caution is advised for patients with liver disease. It may be necessary to adjust the dose of Intimacy Plus 0.03 mg/0.15 mg Tablet in such cases. It is important to consult your doctor before taking this medication. Patients with severe liver disease or active liver disease are not recommended to use Intimacy Plus 0.03 mg/0.15 mg Tablet.

kidney
Limited information is available on using Intimacy Plus 0.03 mg/0.15 mg Tablet in patients with kidney disease. Consult your doctor for advice before using.

alcohol
When taking Intimacy Plus 0.03 mg/0.15 mg Tablet, it is important to be cautious when drinking alcohol. Consult your doctor for guidance on alcohol consumption while on this medication.

driving
It's generally safe to drive while taking Intimacy Plus 0.03 mg/0.15 mg Tablet as it does not typically impact driving abilities.

pregnancy
During pregnancy, it is not safe to use Intimacy Plus 0.03 mg/0.15 mg Tablet. Studies have found harmful effects on developing babies. Consult your doctor for guidance.

breastfeeding
Intimacy Plus 0.03 mg/0.15 mg Tablet should not be used while breastfeeding due to potential toxicity to the baby. It is recommended to consider nonhormonal or progestin-only contraceptives, particularly in the first 4 weeks postpartum.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | - |
₹160
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024